Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1992

AUTHORS

Mauro Magnani , Luigia Rossi , Anna Casabianca , Alessandra Fraternale , Giuditta Schiavano , Giorgio Brandi , Ferdinando Mannello , Giuseppe Piedimonte

ABSTRACT

A broad family of nucleoside analogues are able to inhibit the infectivity and replication of several HIV-1 strains in vitro.1,2 The most popular of these compounds, AZT (3’-azido-3’-deoxythymidine), has been approved in the U.S.A. as a prescription drug since 1987. Although AZT reduces morbidity and mortality associated with severe HIV infection, several toxic effects have limited its long-term administration. 2’,3’-Dideoxycytidine (ddCyd) was subsequently tested clinically3 as potential therapeutic agent. Again ddCyd has shown immunological and virologic improvement in AIDS patients but most individuals developed dose-limiting toxic effects. The same applies to 2’,3’-dideoxyinosine (ddl).4,5 In an attempt to overcome the problem of nucleoside analogue toxicity and to increase their half-life in circulation we have previously synthesized 2’,3’-dideoxycytidine-5’-phosphate (ddCMP) as a prodrug, encapsulated it in human erythrocytes by a procedure of hypotonic hemolysis and resealing, and found that it is dephosphorylated by endogenous pyrimidine nucleotidases and subsequently released by the cells as ddCyd.6 By this way the prodrug is confined within the erythrocytes so that its toxicity is strongly reduced and its delivery is slow enough to ensure a long-lasting plasma concentration.? Unfortunately this drug delivery system does not solve several other problems of nucleoside analogue efficacy. In fact, to be pharmacologically useful dideoxynucleosides must be phosphorylated to 5’-triphosphate by cellular kinases.1,2 Different cell types within the same species have different abilities to phosphorylate these compounds, furthermore, other drugs can potentiate or reduce the activity of these nucleoside analogues by interfering with their metabolism directly or indirectly.8 Macrophages, which are known to be important hosts for HIV-1 with a key role in the propagation of virus as well as in the pathogenesis of AIDS, has low phosphorylating activities. More... »

PAGES

239-245

Book

TITLE

The Use of Resealed Erythrocytes as Carriers and Bioreactors

ISBN

978-1-4613-6321-7
978-1-4615-3030-5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4615-3030-5_30

DOI

http://dx.doi.org/10.1007/978-1-4615-3030-5_30

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1048838706


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Istituto di Chimica Biologica \u201cG. Fornaini\u201d, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magnani", 
        "givenName": "Mauro", 
        "id": "sg:person.0752252542.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752252542.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto di Chimica Biologica \u201cG. Fornaini\u201d, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rossi", 
        "givenName": "Luigia", 
        "id": "sg:person.012733041772.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012733041772.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto di Chimica Biologica \u201cG. Fornaini\u201d, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Casabianca", 
        "givenName": "Anna", 
        "id": "sg:person.01050730564.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050730564.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto di Chimica Biologica \u201cG. Fornaini\u201d, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fraternale", 
        "givenName": "Alessandra", 
        "id": "sg:person.0700661112.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700661112.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto di Igiene, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schiavano", 
        "givenName": "Giuditta", 
        "id": "sg:person.01050566603.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050566603.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto di Igiene, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brandi", 
        "givenName": "Giorgio", 
        "id": "sg:person.01052036725.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052036725.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Urbino", 
          "id": "https://www.grid.ac/institutes/grid.12711.34", 
          "name": [
            "Istituto di Istologia, Universit\u00e0 degli Studi di Urbino, Urbino, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mannello", 
        "givenName": "Ferdinando", 
        "id": "sg:person.01211377324.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211377324.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Parma", 
          "id": "https://www.grid.ac/institutes/grid.10383.39", 
          "name": [
            "Istituto di Patologia Generale, Universit\u00e0 di Parma, Parma, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piedimonte", 
        "givenName": "Giuseppe", 
        "id": "sg:person.01047750544.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047750544.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0140-6736(88)90283-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003135888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(88)90283-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003135888"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.165.6.1737", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006273677"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199005103221901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010879059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-291x(89)91740-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034482446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.86.10.3842", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035401357"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199005103221902", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046712153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(88)90178-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047560310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(88)90178-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047560310"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0092-8240(05)80385-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054613854", 
          "https://doi.org/10.1016/s0092-8240(05)80385-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1699273", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062500854"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1096/fasebj.5.10.1712326", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077327801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1096/fasebj.5.10.2065888", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078192589"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1992", 
    "datePublishedReg": "1992-01-01", 
    "description": "A broad family of nucleoside analogues are able to inhibit the infectivity and replication of several HIV-1 strains in vitro.1,2 The most popular of these compounds, AZT (3\u2019-azido-3\u2019-deoxythymidine), has been approved in the U.S.A. as a prescription drug since 1987. Although AZT reduces morbidity and mortality associated with severe HIV infection, several toxic effects have limited its long-term administration. 2\u2019,3\u2019-Dideoxycytidine (ddCyd) was subsequently tested clinically3 as potential therapeutic agent. Again ddCyd has shown immunological and virologic improvement in AIDS patients but most individuals developed dose-limiting toxic effects. The same applies to 2\u2019,3\u2019-dideoxyinosine (ddl).4,5 In an attempt to overcome the problem of nucleoside analogue toxicity and to increase their half-life in circulation we have previously synthesized 2\u2019,3\u2019-dideoxycytidine-5\u2019-phosphate (ddCMP) as a prodrug, encapsulated it in human erythrocytes by a procedure of hypotonic hemolysis and resealing, and found that it is dephosphorylated by endogenous pyrimidine nucleotidases and subsequently released by the cells as ddCyd.6 By this way the prodrug is confined within the erythrocytes so that its toxicity is strongly reduced and its delivery is slow enough to ensure a long-lasting plasma concentration.? Unfortunately this drug delivery system does not solve several other problems of nucleoside analogue efficacy. In fact, to be pharmacologically useful dideoxynucleosides must be phosphorylated to 5\u2019-triphosphate by cellular kinases.1,2 Different cell types within the same species have different abilities to phosphorylate these compounds, furthermore, other drugs can potentiate or reduce the activity of these nucleoside analogues by interfering with their metabolism directly or indirectly.8 Macrophages, which are known to be important hosts for HIV-1 with a key role in the propagation of virus as well as in the pathogenesis of AIDS, has low phosphorylating activities.", 
    "editor": [
      {
        "familyName": "Magnani", 
        "givenName": "Mauro", 
        "type": "Person"
      }, 
      {
        "familyName": "DeLoach", 
        "givenName": "John R.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4615-3030-5_30", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4613-6321-7", 
        "978-1-4615-3030-5"
      ], 
      "name": "The Use of Resealed Erythrocytes as Carriers and Bioreactors", 
      "type": "Book"
    }, 
    "name": "Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues", 
    "pagination": "239-245", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1048838706"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4615-3030-5_30"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e8a897838227bc4b34c472f3d3afb500e9c5095896ddd19e34e98f68fea99129"
        ]
      }
    ], 
    "publisher": {
      "location": "Boston, MA", 
      "name": "Springer US", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4615-3030-5_30", 
      "https://app.dimensions.ai/details/publication/pub.1048838706"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T08:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000369_0000000369/records_68956_00000001.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-1-4615-3030-5_30"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3030-5_30'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3030-5_30'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3030-5_30'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4615-3030-5_30'


 

This table displays all metadata directly associated to this object as RDF triples.

168 TRIPLES      23 PREDICATES      38 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4615-3030-5_30 schema:about anzsrc-for:11
2 anzsrc-for:1108
3 schema:author Ndd59eed5dcdd405aade4ec1ce777dd3b
4 schema:citation sg:pub.10.1016/s0092-8240(05)80385-4
5 https://doi.org/10.1016/0006-291x(89)91740-3
6 https://doi.org/10.1016/0006-2952(88)90178-5
7 https://doi.org/10.1016/s0140-6736(88)90283-8
8 https://doi.org/10.1056/nejm199005103221901
9 https://doi.org/10.1056/nejm199005103221902
10 https://doi.org/10.1073/pnas.86.10.3842
11 https://doi.org/10.1084/jem.165.6.1737
12 https://doi.org/10.1096/fasebj.5.10.1712326
13 https://doi.org/10.1096/fasebj.5.10.2065888
14 https://doi.org/10.1126/science.1699273
15 schema:datePublished 1992
16 schema:datePublishedReg 1992-01-01
17 schema:description A broad family of nucleoside analogues are able to inhibit the infectivity and replication of several HIV-1 strains in vitro.1,2 The most popular of these compounds, AZT (3’-azido-3’-deoxythymidine), has been approved in the U.S.A. as a prescription drug since 1987. Although AZT reduces morbidity and mortality associated with severe HIV infection, several toxic effects have limited its long-term administration. 2’,3’-Dideoxycytidine (ddCyd) was subsequently tested clinically3 as potential therapeutic agent. Again ddCyd has shown immunological and virologic improvement in AIDS patients but most individuals developed dose-limiting toxic effects. The same applies to 2’,3’-dideoxyinosine (ddl).4,5 In an attempt to overcome the problem of nucleoside analogue toxicity and to increase their half-life in circulation we have previously synthesized 2’,3’-dideoxycytidine-5’-phosphate (ddCMP) as a prodrug, encapsulated it in human erythrocytes by a procedure of hypotonic hemolysis and resealing, and found that it is dephosphorylated by endogenous pyrimidine nucleotidases and subsequently released by the cells as ddCyd.6 By this way the prodrug is confined within the erythrocytes so that its toxicity is strongly reduced and its delivery is slow enough to ensure a long-lasting plasma concentration.? Unfortunately this drug delivery system does not solve several other problems of nucleoside analogue efficacy. In fact, to be pharmacologically useful dideoxynucleosides must be phosphorylated to 5’-triphosphate by cellular kinases.1,2 Different cell types within the same species have different abilities to phosphorylate these compounds, furthermore, other drugs can potentiate or reduce the activity of these nucleoside analogues by interfering with their metabolism directly or indirectly.8 Macrophages, which are known to be important hosts for HIV-1 with a key role in the propagation of virus as well as in the pathogenesis of AIDS, has low phosphorylating activities.
18 schema:editor N50350768f8f64d69b92e9329dfb05d0b
19 schema:genre chapter
20 schema:inLanguage en
21 schema:isAccessibleForFree false
22 schema:isPartOf N143aaa23d0b34c528acb8308a025c2ae
23 schema:name Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues
24 schema:pagination 239-245
25 schema:productId N2d9c9e578de34dfe934d00195d7e88e0
26 N812831e5a3c4426dbd563539286af8a9
27 N86227a3f01624ad596c9302d3b2318df
28 schema:publisher N82777be105114201b3ff5ed8606c2ea1
29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048838706
30 https://doi.org/10.1007/978-1-4615-3030-5_30
31 schema:sdDatePublished 2019-04-16T08:56
32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
33 schema:sdPublisher N014eeb5eb1f0460bb56219b878a03f8a
34 schema:url https://link.springer.com/10.1007%2F978-1-4615-3030-5_30
35 sgo:license sg:explorer/license/
36 sgo:sdDataset chapters
37 rdf:type schema:Chapter
38 N014eeb5eb1f0460bb56219b878a03f8a schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N143aaa23d0b34c528acb8308a025c2ae schema:isbn 978-1-4613-6321-7
41 978-1-4615-3030-5
42 schema:name The Use of Resealed Erythrocytes as Carriers and Bioreactors
43 rdf:type schema:Book
44 N1dd9a4b87f3b4111aaa0d78b1ed6d019 schema:name Istituto di Chimica Biologica “G. Fornaini”, Italy
45 rdf:type schema:Organization
46 N2d9c9e578de34dfe934d00195d7e88e0 schema:name doi
47 schema:value 10.1007/978-1-4615-3030-5_30
48 rdf:type schema:PropertyValue
49 N34f5956ac7ae4f90a27cf49b9082920e schema:name Istituto di Chimica Biologica “G. Fornaini”, Italy
50 rdf:type schema:Organization
51 N469447ff0e0846cab8fb8fdf7ddac178 schema:name Istituto di Igiene, Italy
52 rdf:type schema:Organization
53 N4830e9b6fa384e068b7755db61f2dde0 schema:name Istituto di Chimica Biologica “G. Fornaini”, Italy
54 rdf:type schema:Organization
55 N50350768f8f64d69b92e9329dfb05d0b rdf:first Nc70cd6711a8247f6b270c9202fc75384
56 rdf:rest Nf7ba0d0a23a94b5a9b5be6f20677db0b
57 N503ac9ba1dec4e85a87c43e987f6f316 rdf:first sg:person.012733041772.37
58 rdf:rest N905465d1182a47f58c34ee922eeccfef
59 N812831e5a3c4426dbd563539286af8a9 schema:name readcube_id
60 schema:value e8a897838227bc4b34c472f3d3afb500e9c5095896ddd19e34e98f68fea99129
61 rdf:type schema:PropertyValue
62 N82777be105114201b3ff5ed8606c2ea1 schema:location Boston, MA
63 schema:name Springer US
64 rdf:type schema:Organisation
65 N82baeb5b4fd244599f19d045a30b042e rdf:first sg:person.0700661112.98
66 rdf:rest N84e106b24fa0492291106e70d9d79f7e
67 N84e106b24fa0492291106e70d9d79f7e rdf:first sg:person.01050566603.38
68 rdf:rest Nd75b1921687f4ff484605ddf21015bc9
69 N86227a3f01624ad596c9302d3b2318df schema:name dimensions_id
70 schema:value pub.1048838706
71 rdf:type schema:PropertyValue
72 N8a6691421d5749d6b537166e05edee74 schema:name Istituto di Igiene, Italy
73 rdf:type schema:Organization
74 N905465d1182a47f58c34ee922eeccfef rdf:first sg:person.01050730564.90
75 rdf:rest N82baeb5b4fd244599f19d045a30b042e
76 Nc0477a2f245c42999d27da076d21934f rdf:first sg:person.01211377324.03
77 rdf:rest Nc5cd727cf1f841609f439f0e835ac488
78 Nc5cd727cf1f841609f439f0e835ac488 rdf:first sg:person.01047750544.29
79 rdf:rest rdf:nil
80 Nc70cd6711a8247f6b270c9202fc75384 schema:familyName Magnani
81 schema:givenName Mauro
82 rdf:type schema:Person
83 Nd75b1921687f4ff484605ddf21015bc9 rdf:first sg:person.01052036725.31
84 rdf:rest Nc0477a2f245c42999d27da076d21934f
85 Ndd59eed5dcdd405aade4ec1ce777dd3b rdf:first sg:person.0752252542.98
86 rdf:rest N503ac9ba1dec4e85a87c43e987f6f316
87 Nefc74ae194f74e18a8f2cdaebfa31598 schema:name Istituto di Chimica Biologica “G. Fornaini”, Italy
88 rdf:type schema:Organization
89 Nf7ba0d0a23a94b5a9b5be6f20677db0b rdf:first Nff1fbd009b144358a74e8fb3d9b1b752
90 rdf:rest rdf:nil
91 Nff1fbd009b144358a74e8fb3d9b1b752 schema:familyName DeLoach
92 schema:givenName John R.
93 rdf:type schema:Person
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
98 schema:name Medical Microbiology
99 rdf:type schema:DefinedTerm
100 sg:person.01047750544.29 schema:affiliation https://www.grid.ac/institutes/grid.10383.39
101 schema:familyName Piedimonte
102 schema:givenName Giuseppe
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01047750544.29
104 rdf:type schema:Person
105 sg:person.01050566603.38 schema:affiliation N469447ff0e0846cab8fb8fdf7ddac178
106 schema:familyName Schiavano
107 schema:givenName Giuditta
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050566603.38
109 rdf:type schema:Person
110 sg:person.01050730564.90 schema:affiliation Nefc74ae194f74e18a8f2cdaebfa31598
111 schema:familyName Casabianca
112 schema:givenName Anna
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050730564.90
114 rdf:type schema:Person
115 sg:person.01052036725.31 schema:affiliation N8a6691421d5749d6b537166e05edee74
116 schema:familyName Brandi
117 schema:givenName Giorgio
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01052036725.31
119 rdf:type schema:Person
120 sg:person.01211377324.03 schema:affiliation https://www.grid.ac/institutes/grid.12711.34
121 schema:familyName Mannello
122 schema:givenName Ferdinando
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211377324.03
124 rdf:type schema:Person
125 sg:person.012733041772.37 schema:affiliation N1dd9a4b87f3b4111aaa0d78b1ed6d019
126 schema:familyName Rossi
127 schema:givenName Luigia
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012733041772.37
129 rdf:type schema:Person
130 sg:person.0700661112.98 schema:affiliation N4830e9b6fa384e068b7755db61f2dde0
131 schema:familyName Fraternale
132 schema:givenName Alessandra
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700661112.98
134 rdf:type schema:Person
135 sg:person.0752252542.98 schema:affiliation N34f5956ac7ae4f90a27cf49b9082920e
136 schema:familyName Magnani
137 schema:givenName Mauro
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752252542.98
139 rdf:type schema:Person
140 sg:pub.10.1016/s0092-8240(05)80385-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054613854
141 https://doi.org/10.1016/s0092-8240(05)80385-4
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/0006-291x(89)91740-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034482446
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/0006-2952(88)90178-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047560310
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/s0140-6736(88)90283-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003135888
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1056/nejm199005103221901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010879059
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1056/nejm199005103221902 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046712153
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1073/pnas.86.10.3842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035401357
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1084/jem.165.6.1737 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006273677
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1096/fasebj.5.10.1712326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077327801
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1096/fasebj.5.10.2065888 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078192589
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1126/science.1699273 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062500854
162 rdf:type schema:CreativeWork
163 https://www.grid.ac/institutes/grid.10383.39 schema:alternateName University of Parma
164 schema:name Istituto di Patologia Generale, Università di Parma, Parma, Italy
165 rdf:type schema:Organization
166 https://www.grid.ac/institutes/grid.12711.34 schema:alternateName University of Urbino
167 schema:name Istituto di Istologia, Università degli Studi di Urbino, Urbino, Italy
168 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...